Q4 revenue fell 50% year-over-year to SEK 271,799, with net loss narrowing due to lower costs. Regulatory approval in China marks a major milestone, enabling commercial expansion. CEO resignation and new board chair signal leadership changes.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.